ArticleLaryngoscope investigative otolaryngology2026
Demographic Differences in Diagnosis of Eosinophilic Esophagitis: A Retrospective Analysis.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate trends in coded eosinophilic esophagitis (EoE) diagnosis within the TriNetX healthcare population and the association between food impaction (FI) and subsequent EoE diagnosis across demographic groups. Methods: A retrospective review (2016-2024) was conducted in the TriNetX US Network. Platform-derived annual incidence of coded EoE diagnosis (ICD-10 K20.0) in patients < 21 years was assessed and stratified by sex, race, and ethnicity. Patients presenting with FI (ICD-10 T18.12) were identified, and demographic characteristics of those with and without a subsequent coded EoE diagnosis were compared. The FI analysis did not evaluate endoscopy, biopsy, histology, referral, or other elements of the diagnostic process. Results: A total of 42,519 incident coded EoE diagnoses were identified, with TriNetX-derived diagnosis incidence increasing from 27.8 to 65.8 per 100,000 persons between 2016 and 2024 (136.6% rise). In 2024, males had nearly double the diagnosis rate of females (88.1 vs. 44.2 per 100,000). White patients had the highest diagnosis rate (84.7), compared with Black (31.5), Asian (37.7), and American Indian (62.2) patients. Non-Hispanic patients had higher rates than Hispanic patients (73.3 vs. 30.0). Among 6215 patients presenting with FI (mean age 11.9 ± 6.3 years), 1849 (29.8%) had a subsequent coded EoE diagnosis (mean age 14.7 ± 4.3). Females had lower unadjusted odds than males (OR = 0.5, 95% CI: 0.4-0.5, Conclusion: Within the TriNetX healthcare population, coded pediatric EoE diagnoses increased over time and differed by sex, race, and ethnicity. Following FI, the frequency of subsequent coded EoE diagnosis also differed across demographic groups; these descriptive findings do not establish differences in underlying disease prevalence or diagnostic care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.